Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Crabbe

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Trends in Biochemical Sciences|October 9, 2007
The PI3K inhibitor arsenal: choose your weapon!Tom Crabbe, Melanie J Welham, Stephen G Ward
Acta Crystallographica. Section F, Structural Biology Communications|August 3, 2021
The identification and structural analysis of potential 14-3-3 interaction sites on the bone regulator protein Schnurri-3Lorenzo Soini, Seppe Leysen, Tom Crabbe, et al.
Biochemical Society Symposium|November 1, 2003
Proteases as drug targetsAndy J Docherty, Tom Crabbe, James P O'Connell, et al.
ACS Synthetic Biology|September 15, 2020
Exploiting Single Domain Antibodies as Regulatory Parts to Modulate Monoterpenoid Production in <i>E. coli</i>Jonathan Wilkes, Anthony Scott-Tucker, Mike Wright, et al.
Journal of Biomolecular NMR|February 4, 2006
NMR assignment of the mTOR domain responsible for rapamycin bindingVaclav Veverka, Gregor Lennie, Tom Crabbe, et al.
The FEBS Journal|July 10, 2024
Enhanced stabilisation and reduced fibril forming potential of an amyloidogenic light chain using a variable heavy domain to mimic the homodimer complexAlana Maerivoet, Rebecca Price, Cécile Galmiche, et al.
European Journal of Biochemistry|May 21, 2003
Investigation of the kinetics and order of tyrosine phosphorylation in the T-cell receptor zeta chain by the protein tyrosine kinase LckHazel R Housden, Paul J S Skipp, Matthew P Crump, et al.
Bioorganic & Medicinal Chemistry Letters|September 9, 2008
Optimization of a series of multi-isoform PI3 kinase inhibitorsBenjamin Perry, Rebekah Beevers, Gavin Bennett, et al.
Journal of Leukocyte Biology|July 1, 2008
Evidence for PI-3K-dependent migration of Th17-polarized cells in response to CCR2 and CCR6 agonistsAdam Webb, Andrew Johnson, Mara Fortunato, et al.
Journal of Molecular Biology|July 24, 2021
A Structural Study of the Cytoplasmic Chaperone Effect of 14-3-3 Proteins on Ataxin-1Seppe Leysen, Rebecca Jane Burnley, Elizabeth Rodriguez, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Trends in Biochemical Sciences|October 9, 2007
The PI3K inhibitor arsenal: choose your weapon!Tom Crabbe, Melanie J Welham, Stephen G Ward
Acta Crystallographica. Section F, Structural Biology Communications|August 3, 2021
The identification and structural analysis of potential 14-3-3 interaction sites on the bone regulator protein Schnurri-3Lorenzo Soini, Seppe Leysen, Tom Crabbe, et al.
Biochemical Society Symposium|November 1, 2003
Proteases as drug targetsAndy J Docherty, Tom Crabbe, James P O'Connell, et al.
ACS Synthetic Biology|September 15, 2020
Exploiting Single Domain Antibodies as Regulatory Parts to Modulate Monoterpenoid Production in <i>E. coli</i>Jonathan Wilkes, Anthony Scott-Tucker, Mike Wright, et al.
Journal of Biomolecular NMR|February 4, 2006
NMR assignment of the mTOR domain responsible for rapamycin bindingVaclav Veverka, Gregor Lennie, Tom Crabbe, et al.
The FEBS Journal|July 10, 2024
Enhanced stabilisation and reduced fibril forming potential of an amyloidogenic light chain using a variable heavy domain to mimic the homodimer complexAlana Maerivoet, Rebecca Price, Cécile Galmiche, et al.
European Journal of Biochemistry|May 21, 2003
Investigation of the kinetics and order of tyrosine phosphorylation in the T-cell receptor zeta chain by the protein tyrosine kinase LckHazel R Housden, Paul J S Skipp, Matthew P Crump, et al.
Bioorganic & Medicinal Chemistry Letters|September 9, 2008
Optimization of a series of multi-isoform PI3 kinase inhibitorsBenjamin Perry, Rebekah Beevers, Gavin Bennett, et al.
Journal of Leukocyte Biology|July 1, 2008
Evidence for PI-3K-dependent migration of Th17-polarized cells in response to CCR2 and CCR6 agonistsAdam Webb, Andrew Johnson, Mara Fortunato, et al.
Journal of Molecular Biology|July 24, 2021
A Structural Study of the Cytoplasmic Chaperone Effect of 14-3-3 Proteins on Ataxin-1Seppe Leysen, Rebecca Jane Burnley, Elizabeth Rodriguez, et al.
Pageof 2